ORIONS Money Stocks

[AugustaFriends]

ZLCS looks good, but IMO be careful, play the Bounce after R/S- and new ticker.. but looks like they might be Diluting soon after.

Correct me if I am wrong.. always have problems with these documents:

1. Below it mentions the R/S 1/10 -
2. They now have 300,000,000 million authorized.. this is the new A/S.. so even if it drops to 6 Million tomorrow, they have a huge A/S. (this is where I see a big Red Flag.)

ONCE AGAIN stocks bounce great after a 50% correction on R/S, so I say PLAY ZLCS at the right time, but be careful, most of the time Dilution continues.


http://biz.yahoo.com/e/140715/zlcs8-k.html

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Increase in Authorized Shares

On July 15, 2014, after receiving the requisite approval of the Company's stockholders at its 2014 annual meeting of stockholders (the "Annual Meeting"), the Company amended its certificate of incorporation to increase the number of authorized shares of Common Stock from 200,000,000 to 300,000,000 and to change the name of the Company from Zalicus Inc. to EPIRUS Biopharmaceuticals, Inc.

A copy of the Certificate of Amendment is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Reverse Stock Split

As described in the Prospectus, at the Company's annual meeting of stockholders held on July 15, 2014, the Company's stockholders approved the Certificate of Amendment, pursuant to which any whole number of outstanding shares between and including six (6) and twelve (12) would be combined and reclassified into one share of Common Stock, with the final ratio to be determined by the Company's board of directors as set forth in more detail in the Prospectus. Thereafter, the Company's board of directors determined to effect a 1-for-10 reverse stock split (the "Reverse Stock Split") and authorized the implementation of the Reverse Stock Split and the filing of the Certificate of Amendment (the "Reverse Split Amendment"). In connection with the Closing, the Company filed the Reverse Split Amendment to become effective at 12:01 a.m. on July 16, 2014.

As a result of the Reverse Stock Split, every ten (10) shares of the Company's pre-Reverse Stock Split Common Stock will be combined and reclassified into one
(1) share of the Common Stock. Beginning with the opening of trading on July 16, 2014, the Company's Common Stock will trade on the NASDAQ Capital Market on a Reverse Stock Split adjusted basis with a new CUSIP number of 29428P 107.

No fractional shares will be issued in connection with the Reverse Stock Split. In accordance with the Certificate of Amendment, stockholders of the Company who would have otherwise been due a fractional share will receive a cash payment instead of such fractional share determined on the basis of the closing price of the Common Stock on the NASDAQ Capital Market on July 15, 2014, the last business day before the effective date of the Reverse Stock Split. Proportional adjustments will be made to the Company's outstanding warrants, stock options and other equity awards and to the Company's equity compensation plans to reflect the Reverse Stock Split.

A copy of the Certificate of Amendment is filed as Exhibit 3.2 to this Current Report on Form 8-K and is incorporated herein by reference.